BERWYN, Pa., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other ...
WASHINGTON — BIO’s new CEO John Crowley is making changes. He’s pivoting the biotechnology industry’s largest trade association away from a focus on controversial social issues. He dramatically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results